News
New weight loss pill could benefit people with Type 2 diabetes: Drugmaker
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce hemoglobin A1C levels on average by 1.3-1.6% and also help people lose up to 16 pounds, or about 7.9% of their body weight.
Clinical Trials Arena on MSN13h
Eli Lilly’s shares up as oral GLP-1RA scores in first Phase III trialLilly plans to submit orforglipron for approval in weight management by the end of 2025, with a type 2 diabetes application ...
A once-daily oral GLP-1 conferred greater reductions in HbA1c and body weight than placebo among adults with type 2 diabetes, ...
Loss of skeletal muscle mass is a known risk factor for falls. Researchers from the University of Tsukuba conducted a 5-yr follow-up study on 471 patients with type 2 diabetes and found that ...
Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.
News-Medical.Net on MSN2d
New findings highlight a shifting landscape for weight loss and glucose managing medicationsWhen it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback